![Lisa McNeil](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lisa McNeil
Corporate Officer/Principal bei Elicio Therapeutics, Inc. (Old)
Aktive Positionen von Lisa McNeil
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Karriereverlauf von Lisa McNeil
Ausbildung von Lisa McNeil
University of Michigan | Undergraduate Degree |
Emory University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Elicio Therapeutics, Inc. (Old)
![]() Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Lisa McNeil
- Erfahrung